A detailed history of Baker Chad R transactions in Novo Nordisk A S stock. As of the latest transaction made, Baker Chad R holds 5,180 shares of NVO stock, worth $544,210. This represents 0.12% of its overall portfolio holdings.

Number of Shares
5,180
Previous 5,380 3.72%
Holding current value
$544,210
Previous $767,000 19.69%
% of portfolio
0.12%
Previous 0.16%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$119.07 - $145.42 $23,814 - $29,083
-200 Reduced 3.72%
5,180 $616,000
Q4 2023

Jan 22, 2024

SELL
$87.78 - $105.45 $21,945 - $26,362
-250 Reduced 4.44%
5,380 $556,000
Q3 2023

Oct 17, 2023

BUY
$90.94 - $199.54 $303,284 - $665,465
3,335 Added 145.32%
5,630 $511,000
Q2 2023

Jul 18, 2023

SELL
$155.98 - $172.65 $15,597 - $17,265
-100 Reduced 4.18%
2,295 $371,000
Q1 2023

Apr 27, 2023

BUY
$132.34 - $159.14 $316,954 - $381,140
2,395 New
2,395 $381,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Baker Chad R Portfolio

Follow Baker Chad R and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Chad R, based on Form 13F filings with the SEC.

News

Stay updated on Baker Chad R with notifications on news.